SCHEMBL9743805

SCHEMBL9743805

CCOC(=O)C(N)/C=C/CP

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2D6 P10635 1/20 0.44
CYP2C9 P11712 1/20 0.44
CYP2C19 P33261 1/20 0.44
ALOX15 P16050 1/20 0.37
ALDH1A1 P00352 2/20 0.34
LMNA P02545 1/20 0.33
HSD17B10 Q99714 1/20 0.33
MGAM O43451 1/20 0.32
GAA P10253 1/20 0.32
SI P14410 1/20 0.32
MGAM2 Q2M2H8 1/20 0.32
SOAT1 P35610 1/20 0.32
CAD P27708 1/20 0.32
HCAR2 Q8TDS4 1/20 0.31
METAP2 P50579 1/20 0.31
METAP1 P53582 1/20 0.31
CA12 O43570 1/20 0.31
CA1 P00915 1/20 0.31
CA2 P00918 1/20 0.31
CA9 Q16790 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9743811 1.00 CYP2D6 (0.44) CYP2D6CYP2C9CYP2C19ALOX15ALDH1A1
SCHEMBL10755241 0.84 CYP2D6 (0.46) CYP2D6CYP2C9CYP2C19ALOX15ALDH1A1
SCHEMBL9745890 0.82 ATM (0.43) CYP2C9CYP2C19ALDH1A1LMNAHCAR2
SCHEMBL9745874 0.82 ATM (0.43) CYP2C9CYP2C19ALDH1A1LMNAHCAR2
SCHEMBL9468653 0.78 CYP2D6 (0.47) CYP2D6CYP2C9CYP2C19ALOX15ALDH1A1
SCHEMBL9468728 0.78 CYP2D6 (0.47) CYP2D6CYP2C9CYP2C19ALOX15ALDH1A1
SCHEMBL9744820 0.77 CYP2D6 (0.55) CYP2D6CYP2C9CYP2C19ALOX15ALDH1A1
SCHEMBL9744815 0.77 CYP2D6 (0.55) CYP2D6CYP2C9CYP2C19ALOX15ALDH1A1
SCHEMBL22329028 0.76 CYP2D6 (0.46) CYP2D6CYP2C9CYP2C19ALOX15ALDH1A1
SCHEMBL29253119 0.73 CYP2D6 (0.44) CYP2D6CYP2C9CYP2C19ALOX15ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5175344-A Anticonvulsants, anxiolytic agents CIBA-GEIGY CORPORATION (US) 1992-12-29 US disclosed
EP-0233154-B1 UNSATURATED AMINO-ACIDS CIBA-GEIGY AG (CH) 1991-12-18 EP disclosed
US-5051413-A For treatment of ischemia, antispasmodic agents, anticonvulsants and anxiety or manic conditions CIBA-GEIGY CORPORATION (US) 1991-09-24 US disclosed
EP-0302826-A2 Process for the preparation of unsaturated amino acid compounds CIBA-GEIGY AG (CH) 1989-02-08 EP disclosed